PC Bottom in Sight? How EU Hurts Gene Drug Sales

In this week’s Bloomberg podcast, Bloomberg Intelligence analysts discuss the findings and impacts of their research: 

Kenvue Faces Margin Test Post $41.6 Billion IPO -- Diana Gomes looks at the challenges facing the newly public company out of Johnson & Johnson. 

EBay Looks Toward Rising Take Rate for Revenue Push -- Poonam Goyal lays out the potential for a key metric for the company. 

PC Bottom in Sight for Dell, HP, Lenovo as AMD, Intel Hold Fast -- Woo Jin Ho explains why the shrinking PC market should bottom out by midyear.

EU Payment Fight Could Cut 40% From Gene Therapy Sales -- Ann-Hunter Van Kirk looks at the impact of EU regulators resisting high drug prices.

New-Home Demand Rebuilds as Battered Markets Lead Broad Rebound -- Drew Reading explains the improving state of sales across the country.

The Bloomberg Intelligence radio show with Paul Sweeney and Alix Steel podcasts through Apple’s iTunes, Spotify and Luminary. It broadcasts on Saturdays and Sundays at noon on Bloomberg’s flagship station WBBR (1130 AM) in New York, 106.1 FM/1330 AM in Boston, 99.1 FM in Washington, 960 AM in the San Francisco area, channel 119 on SiriusXM, www.bloombergradio.com, and iPhone and Android mobile apps.

Bloomberg Intelligence, the research arm of Bloomberg L.P., has more than 400 professionals who provide in-depth analysis on more than 2,000 companies and 135 industries while considering strategic, equity and credit perspectives. BI also provides interactive data from over 500 independent contributors. It is available exclusively for Bloomberg Terminal subscribers. Run {BI <GO>}.

See omnystudio.com/listener for privacy information.